People channel feed

As sup­ply chain wor­ries ease up, Big Phar­ma CEOs have a new top con­cern: re­cruit­ing and keep­ing em­ploy­ees

4 years ago
Pharma

Zio­pharm lays off half its staff af­ter man­u­fac­tur­ing is­sues force de­lays

4 years ago
Pharma
Manufacturing

Trevor Bed­ford, Cigall Kadoch among this year's in­com­ing HH­MI in­ves­ti­ga­tors

4 years ago
Financing

Fore­site re­cruits Prin­cip­ia vet Mar­tin Babler — and his old team — to oc­cu­py the C-suite of a start­up

4 years ago
Startups

The fire un­der Glax­o­SmithK­line's Em­ma Walm­s­ley grows as an­oth­er well-known ac­tivist in­vestor grabs its pitch­fork — re­port

4 years ago
Pharma

So what hap­pened with No­var­tis Gene Ther­a­pies? Here's your an­swer

4 years ago
Bioregnum

Aerie fires CEO af­ter lead pro­gram flop, com­ments about pri­ma­ry end­points be­ing 'not re­quired'

4 years ago
Pharma

Fresh off Fer­Gene's melt­down, David Meek takes over at Mi­rati with lead KRAS drug rac­ing to an ap­proval

4 years ago

Back-to-back piv­otal fail­ures force Ther­a­vance to lay off 270 staffers, prune R&D fo­cus

4 years ago
R&D

Five Prime founder Rusty Williams sets out to test the lim­its of cell ther­a­py with ax­olotl-in­spired biotech

4 years ago
Financing
Startups

Biotech's 'found­ing fa­ther' and in­flu­en­tial deal bro­ker Fred Frank dies at 89

4 years ago

In­de­pen­dent in­ves­ti­ga­tion con­firms sex­u­al ha­rass­ment al­le­ga­tions against Aubrey de Grey

4 years ago

Mar­tin Shkre­li to go toe-to-toe with new FTC chair over Dara­prim price spikes

4 years ago

Ex­clu­sive: Prison and multi­bil­lion dol­lar buy­outs lat­er, Sam Wak­sal is all in on the biotech game, with some big-name back­ers

4 years ago
Startups

A few months in­to his new role at At­tralus, ex-Pur­due chief Mark Tim­ney leads the biotech to a $116M round

4 years ago
Financing

Mod­er­na sur­faces as the first part­ner for Jim Wilson's rare dis­ease non­prof­it, do­nat­ing an mR­NA pro­gram at no cost

4 years ago
Pharma

As blue­bird plans its big split, rare dis­ease head An­drew Oben­shain re­cruits Iron­wood vet as CFO

4 years ago

UK unions lam­bast plan for ma­jor lay­offs at MHRA as Brex­it takes its toll

4 years ago
Pharma

There's a new an­ti-ag­ing up­start in town — and it's re­port­ed­ly backed by Ama­zon bil­lion­aire Jeff Be­zos

4 years ago
Startups

Ex­elix­is mourns the deaths of two long­time ex­ec­u­tives

4 years ago

Sack­lers win im­mu­ni­ty from opi­oid law­suits as Pur­due Phar­ma is dis­solved in bank­rupt­cy set­tle­ment

4 years ago
Pharma

Scoop: In­spired by the late Tachi Ya­ma­da, Jim Wil­son launch­es new non­prof­it tar­get­ing un­der­served ul­tra-rare dis­eases

4 years ago
Pharma

In a ma­jor blow to vac­cine ef­forts, se­nior FDA lead­ers step­ping down

4 years ago
FDA+

Te­va re­cruits Tal Zaks to its board, of­fer­ing $300K+ pay pack­age and seam­less tran­si­tion from Mod­er­na

4 years ago
First page Previous page 53545556575859 Next page Last page
A service from the Financial Times